Suppr超能文献

补体系统与激肽系统在血管通透性中的相互作用。

Cross-talk between the complement and the kinin system in vascular permeability.

机构信息

Department of Life Sciences, University of Trieste, via Valerio 28, 34127 Trieste, Italy.

出版信息

Immunol Lett. 2011 Oct 30;140(1-2):7-13. doi: 10.1016/j.imlet.2011.06.006. Epub 2011 Jul 6.

Abstract

The endothelium is a continuous physical barrier that regulates coagulation and selective passage of soluble molecules and circulating cells through the vessel wall into the tissue. Due to its anatomic localization, the endothelium may establish contact with components of the complement, the kinin and the coagulation systems which are the main, though not exclusive, inducers of vascular leakage. Although the complement and the kinin systems may act independently, increasing evidence suggest that there is a crosstalk that involve different components of both systems. Activation is required for the function of the two systems which are involved in pathological conditions such as hereditary and acquired angioedema (AE) and vasculitidis. The aim of this review is to discuss the contribution of complement and kinin systems to vascular leakage and the cross-talk between the two systems in the development of AE. This clinical condition is characterized by episodic and recurrent local edema of subcutaneous and submucosal tissues and is due to inherited or acquired C1-INH deficiency. Although the pathogenesis of the swelling in patients with AE was originally thought to be mediated by C2, ample evidence indicate bradykinin (BK) as the most effective mediator even though the possibility that both the complement and the kinin-forming systems may contribute to the edema has not been completely excluded. BK induces endothelial leakage interacting with B2 receptors but other molecules may be involved in the onset and maintenance of AE. In this review we shall discuss the role of B1 receptors and gC1qR/p33 in addition to that of B2 receptors in the onset of AE attacks and the importance of these receptors as new possible molecular targets for therapy.

摘要

内皮细胞是一种连续的物理屏障,可调节凝血和可溶性分子及循环细胞通过血管壁选择性地进入组织。由于其解剖位置,内皮细胞可能与补体、激肽和凝血系统的成分接触,这些成分是血管渗漏的主要(尽管不是唯一)诱导物。虽然补体和激肽系统可以独立作用,但越来越多的证据表明,这两个系统之间存在涉及不同成分的串扰。两种系统的激活是其发挥功能所必需的,它们参与遗传性和获得性血管性水肿(AE)和血管炎等病理状况。本综述的目的是讨论补体和激肽系统对血管渗漏的贡献,以及这两个系统在 AE 发病机制中的相互作用。这种临床病症的特征是皮下和黏膜下组织的局部间歇性和复发性水肿,是由于遗传或获得性 C1-INH 缺乏引起的。尽管最初认为 AE 患者的肿胀是由 C2 介导的,但大量证据表明缓激肽(BK)是最有效的介质,尽管补体和激肽形成系统都可能导致水肿的可能性尚未完全排除。BK 通过与 B2 受体相互作用诱导内皮细胞渗漏,但其他分子可能参与 AE 的发作和维持。在本综述中,我们将讨论 B1 受体和 gC1qR/p33 的作用,除了 B2 受体在 AE 发作中的作用,以及这些受体作为新的可能的治疗分子靶点的重要性。

相似文献

1
Cross-talk between the complement and the kinin system in vascular permeability.
Immunol Lett. 2011 Oct 30;140(1-2):7-13. doi: 10.1016/j.imlet.2011.06.006. Epub 2011 Jul 6.
2
The Role of Complement in Hereditary Angioedema.
Transfus Med Rev. 2019 Oct;33(4):243-247. doi: 10.1016/j.tmrv.2019.08.002. Epub 2019 Aug 29.
3
Hereditary angioedema attack: what happens to vasoactive mediators?
Int Immunopharmacol. 2020 Jan;78:106079. doi: 10.1016/j.intimp.2019.106079. Epub 2019 Dec 13.
4
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.
J Allergy Clin Immunol. 2009 Dec;124(6):1303-10.e4. doi: 10.1016/j.jaci.2009.08.007.
5
Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Expert Opin Pharmacother. 2012 Oct;13(15):2233-47. doi: 10.1517/14656566.2012.723692. Epub 2012 Sep 13.
6
Update on therapeutic developments for hereditary angioedema.
Allergy Asthma Proc. 2009 Sep-Oct;30(5):500-5. doi: 10.2500/aap.2009.30.3282.
7
The plasma bradykinin-forming pathways and its interrelationships with complement.
Mol Immunol. 2010 Aug;47(13):2161-9. doi: 10.1016/j.molimm.2010.05.010.
8
Current pharmacotherapy of bradykinin-mediated angioedema.
Expert Opin Pharmacother. 2013 Apr;14(5):571-86. doi: 10.1517/14656566.2013.778826.
9
Hereditary angioedema: the plasma contact system out of control.
J Thromb Haemost. 2018 Sep;16(9):1674-1685. doi: 10.1111/jth.14209. Epub 2018 Jul 17.
10
Role of the B1 bradykinin receptor and gC1qR/p33 in angioedema.
Immunol Allergy Clin North Am. 2013 Nov;33(4):535-44. doi: 10.1016/j.iac.2013.07.008. Epub 2013 Sep 5.

引用本文的文献

1
Pathogenicity and virulence of Rodent-Borne Orthohantaviruses.
Virulence. 2025 Dec;16(1):2553784. doi: 10.1080/21505594.2025.2553784. Epub 2025 Sep 4.
2
Impact of smoking on the complement system: a narrative review.
Front Immunol. 2025 Jun 19;16:1619835. doi: 10.3389/fimmu.2025.1619835. eCollection 2025.
3
Kinin B Receptor Agonist Enhances Blood-Brain Barrier Permeability in Healthy and Glioblastoma Environments.
Pharmaceuticals (Basel). 2025 Apr 18;18(4):591. doi: 10.3390/ph18040591.
4
Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate.
J Intensive Med. 2024 Apr 10;4(4):453-467. doi: 10.1016/j.jointm.2024.02.003. eCollection 2024 Oct.
5
Assessment of the effect of 21-day head-down bed rest on the cardiovascular system by blood protein composition.
Front Physiol. 2024 Jun 20;15:1375929. doi: 10.3389/fphys.2024.1375929. eCollection 2024.
6
Kinin B receptor and TLR4 interaction in inflammatory response.
Inflamm Res. 2024 Sep;73(9):1459-1476. doi: 10.1007/s00011-024-01909-1. Epub 2024 Jul 4.
8
9
Indices of complement activation and coagulation changes in trauma patients.
Trauma Surg Acute Care Open. 2022 Sep 14;7(1):e000927. doi: 10.1136/tsaco-2022-000927. eCollection 2022.
10
Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy.
J Venom Anim Toxins Incl Trop Dis. 2021 Dec 6;27:e20200181. doi: 10.1590/1678-9199-JVATITD-2020-0181. eCollection 2021.

本文引用的文献

2
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
N Engl J Med. 2010 Aug 5;363(6):532-41. doi: 10.1056/NEJMoa0906393.
3
Complement: a key system for immune surveillance and homeostasis.
Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19.
5
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.
J Allergy Clin Immunol. 2009 Dec;124(6):1303-10.e4. doi: 10.1016/j.jaci.2009.08.007.
6
Paths reunited: Initiation of the classical and lectin pathways of complement activation.
Immunobiology. 2010;215(1):1-11. doi: 10.1016/j.imbio.2009.08.006. Epub 2009 Sep 27.
8
Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition.
Biochem Biophys Res Commun. 2009 Oct 16;388(2):205-11. doi: 10.1016/j.bbrc.2009.07.135. Epub 2009 Aug 5.
10
Production of C5a by ASP, a serine protease released from Aeromonas sobria.
J Immunol. 2008 Sep 1;181(5):3602-8. doi: 10.4049/jimmunol.181.5.3602.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验